April 2017 – Lacerta Bio

Biosimilars: Who wants to play this game?

Post author:Carlos
Post published:April 14, 2017
Post category:Biosimilars
Post comments:0 Comments

A recent post by Robert Wessman of Alvogen pointed out that some companies are abandoning their efforts in the biosimilars markets. Amgen, for instance, recently decided to postpone…

Visit to England: What Did We Learn?

Post author:Carlos
Post published:April 4, 2017
Post category:Europe Government
Post comments:0 Comments

We just returned from a brief trip to England, where we met with a client, plus a few friends and colleagues. Over several meetings and meals, three issues consistently came…

Get in touch